Clinical problems and thoughts on the treatment of neovascular glaucoma

Author: Zhao Mingwei
DOI: 10.3760/cma.j.issn.2095-0160.2016.07.001
Published 2016-07-10
Cite as Chin J Exp Ophthalmol, 2016,34(7): 577-579.

Abstract                            [Download PDF] [Read Full Text]

Neovascular glaucoma (NVG) is a dreadful pathology and it will be rapid spontaneous evolution responsible for eventual visual loss in many cases, with poor therapeutic efficiency.The main challenges in clinical practice for the management of NVG are as follows: (1)What is the goal of NVG treatment, to decrease intraocular pressure (IOP) or to reserve visual function? (2)How to create an optimal condition or timing for the treatment of primary disease? (3)What is exactly the key of NVG treatment? Anti-vascular endothelial growth factor (VEGF) medication, anti-glaucoma surgery or pan-retinal photocoagulation (PRP) for strict control of clinical situations potentially responsible for retinal ischemia ? (4)How to set up a comprehensive management strategy for NVG? In this paper, we established a comprehensive treatment strategy for NVG, including a core aim for preserving visual function, a goal of completing PRP and the main methods of anti-VEGF injection and anti-glaucoma surgery in order to preserve visual status of NVG patients as much as possible.

Key words:
Glaucoma, neovascular/therapy; Ischemia/complications; Retinal diseases/complications; Neovascularization, pathologic; Ocular hypertension/therapy; Anti-VEGF therapy; Pan-retinal photocoagulation; Visual acuity

Contributor Information

Zhao Mingwei
Department Of Ophthalmology, Peking University People’s Hospital, Key Laboratory of Vision Loss and Restoration of Ministry of Education, Beijing 100044, China
(Read 54 times, 1 visits today)
Updated: February 22, 2023 — 8:20 am